Cite

HARVARD Citation

    Huselton, E. et al. (2021). A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes. Leukemia & lymphoma. 62 (6), pp. 1441-1449. [Online]. 
  
Back to record